Viral Hepatitis C - Schering-Plough Drug Gets Fast Track

Schering-Plough Drug Gets Fast Track
MSN MoneyCentral - KENILWORTH, N.J. (AP) - Drug maker Schering-Plough Corp. said Monday that regulators granted "fast track" status to its experimental hepatitis C treatment. The Food and Drug Administration gives the fast track label -- which sometimes helps speed the

Aethlon Medical Announces Avian Flu Treatment Application
Genetic Engineering News - Aethlon Medical, Inc., (OTCBB:AEMD), a pioneer in developing therapeutic devices for infectious disease, announced today that it is expanding the applications of its Hemopurifier(TM) treatment technology to include the H5N1 strain of the Avian Flu

Viral Hepatitis and HIV Coinfection
Medscape News - In Western countries, chronic HBV infection affects 5% to 10% of HIV-positive individuals. However, a larger proportion of the HIV-infected population has been exposed to HBV in the past. Isolated hepatitis B core antibody (anti-HBc) is more common

FDA Grants Fast Track Designation To Oral HCV Protease Inhibitor SCH
Medical News Today - Schering-Plough today reported that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to its investigational oral hepatitis C protease inhibitor (SCH 503034), currently in Phase II clinical development for the treatment

Home paper shredders pose serious injury risk to toddlers
RxPG - By New York University Medical Center and School of Medicine, As our environments change over time with technology, pediatric emergency specialists are continuously challenged to observe possible trends and prevent more injuries by educating the